ArticleJournal of translational medicine2025

A novel peptide encoded by circSRCAP confers resistance to enzalutamide by inhibiting the ubiquitin-dependent degradation of AR-V7 in castration-resistant prostate cancer.

Xiannan Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.